Berkeley Lights Stock
Cell Manipulation for Personalized Therapies
Sign up today and learn more about Berkeley Lights Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Berkeley Lights Stock
Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. It aims to provide platforms that automate the manipulation and analysis of cells. The Beacon platform, the company's flagship product, is suited for cell line development, antibody discovery, gene editing, and antibody engineering workflows. The platform uses optofluidics and light-based technology to automate the work of cloning, culturing and sorting specific cells from biological samples. By automating these processes, they aim to cut the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing.
On June 26, 2020, Berkeley Lights filed to go public. Click here to see Berkeley Light's IPO paperwork.
The company was founded in 2011 in Emeryville, California.
Black Diamond Ventures
Zymergen, Gusto, Berkeley Lights, Eight Sleep, OpenGov, Bonobos, Movandi, Bossa Nova Robotics, inDinero
Paxion Capital Partners
Innovium, H2O.ai, Berkeley Lights, Bossa Nova Robotics, Katerra
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Walden Riverwood Ventures
Chief Executive Officer
Chief Financial Officer
Chief Scientific Officer
Kevin Chapman, Ph.D.
Chief Technology Officer
Keith Breinlinger, Ph.D.
Vice President, People Operations
John Proctor, Ph.D.
SVP, Global Sales
nanalyze - Jul, 5 2020All About the Berkeley Lights Stock IPO
GlobeNewswire - May, 12 2020Abveris Announces Human Antibody Discovery Partnership with Nkarta using the Trianni Mouse® on the Berkeley Lights Beacon®
PR Newswire - Apr, 27 2020Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies T
San Francisco Business Times - Mar, 13 2020How the coronavirus validated Berkeley Lights' technology and its supply chain
PR Newswire - Mar, 9 2020Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics
PR Newswire - Feb, 28 2020Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19
PR Newswire - Jan, 2 2020Berkeley Lights Launches Culture Station to Increase Capacity of its Beacon® and Lightning™ Optofluidic Platforms
fiercebiotech - Oct, 1 2019Ginkgo forms $150M cell screening pact with Berkeley Lights
synbiobeta - Sep, 16 2019The growth and bottlenecks of synthetic biology: say hello to Berkeley Lights
finance - Sep, 5 2019Berkeley Lights Opens Shanghai Location
prnewswire - Aug, 7 2019Berkeley Lights Names Sarah Boyce To Board of Directors
prnewswire - Jun, 10 2019Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strains
bioportfolio - May, 18 2019ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase